17. Has clinically significant abnormal laboratory value(s), other than those consistent with stage 5 chronic kidney disease. Aspartate aminotransferase or alanine aminotransferase >1.5 × the upper limit of the reference range or total bilirubin >1.5 × the upper limit of the reference range. A single repeat is allowed for eligibility determination;